Cuban Abdala vaccine: Effectiveness in preventing severe disease and death from COVID-19 in Havana, Cuba; A cohort study

• Main Authors: Pedro I. Más-Bermejo (Author), Félix O. Dickinson-Meneses (Author), Kenia Almenares-Rodríguez (Author), Lizet Sánchez-Valdés (Author), Raúl Guinovart-Díaz (Author), María Vidal-Ledo (Author), Enrique Galbán-García (Author), Yadira Olivera-Nodarse (Author), Isabel Morgado-Vega (Author), Santiago Dueñas-Carrera (Author), Merardo Pujol (Author), Francisco Hernández-Bernal (Author), Miladys Limonta-Fernández (Author), Gerardo Guillén-Nieto (Author), Verena L. Muzio-González (Author), Marta Ayala-Ávila (Author)
• Format: Book
• Published: Elsevier, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: COVID-19 vaccines have proven safe and efficacious in reducing severe illness and death. Cuban protein subunit vaccine Abdala has shown safety, tolerability and efficacy (92·3% [95% CI: 85·7‒95·8]) against SARS-CoV-2 in clinical trials. This study aimed to estimate Abdala's...